Covered recipient · General Payments record
BHUPINDERJIT BALLAGAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$1,703.56
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $304.25 | 14 |
| Education | $74.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $131.98 | 3 |
| Janssen Biotech, Inc. | $51.27 | 2 |
| ABBVIE INC. | $41.00 | 2 |
| Merck Sharp & Dohme Corporation | $38.27 | 2 |
| ARRAY BIOPHARMA INC | $23.79 | 1 |
| Daiichi Sankyo Inc. | $20.59 | 1 |
| Lilly USA, LLC | $19.42 | 1 |
| Regeneron Healthcare Solutions, Inc. | $19.00 | 1 |
| AVEO Pharmaceuticals, Inc. | $18.88 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.67 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106476729 | CMS |
| ABBVIE INC. | $23.33 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106476731 | CMS |
| ARRAY BIOPHARMA INC | $23.79 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131801908 | CMS |
| Aveo Pharmaceuticals, Inc. | $18.88 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143490586 | CMS |
| Daiichi Sankyo Inc. | $20.59 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089396689 | CMS |
| Janssen Biotech, Inc. | $26.83 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078779569 | CMS |
| Janssen Biotech, Inc. | $24.44 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078779557 | CMS |
| Lilly USA, LLC | $19.42 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135563710 | CMS |
| Merck Sharp & Dohme LLC | $16.11 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141589276 | CMS |
| Merck Sharp & Dohme LLC | $22.16 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141589278 | CMS |
| Novartis Pharmaceuticals Corporation | $15.04 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086692071 | CMS |
| Regeneron Healthcare Solutions, Inc. | $19.00 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114269149 | CMS |
| SOBI, INC | $32.69 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141415698 | CMS |
| SOBI, INC | $24.30 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141420328 | CMS |
| SOBI, INC | $74.99 | 12/12/2024 | Education | Undisputed | 01/23/2026 | 1141427787 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.